ATS Medical (Minneapolis) reported that the U.S. Securities and Exchange Commission has declared effective the company's registration statement concerning its proposed acquisition of 3F Therapeutics (Lake Forest, California). Unveiled in January, the deal, with milestones, has been valued at $58 million. The company will hold its annual meeting on Sept. 25 for a vote on the acquisition.